We read the paper by Kondratowicz et al with interest, in which it was concluded that the lymphadenopathy and lymphocytosis in rheumatoid arthritis (RA) could be active features of this multiorgan disease.' Although the panel of lymphocyte markers used in their study was fairly comprehensive, it did not include CD5 (TI) antigen. Recent documented findings showed that peripheral B lymphocytes of patients with certain autoimmune diseases, including rheumatoid arthritis, express CD5 (TI) antigen, a marker for T cells and most B lineage chronic lymphocytic leukaemia.23 We believe that the authors' study should have included CD5 antigen so as to enhance the understanding of lymphoid hyperplasia in rheumatoid lymphadenopathy. A case in which a 68 year old patient with a 20 year history of seropositive rheumatoid arthritis and generalised cervical lymphadenopathy was briefly described4; both peripheral blood lymphocytes and those from the lymph node showed a significant increase in CD5 positive B cells.
Histologically, this patient's lymph node showed substantial expansion of the T dependent paracortical zone by a monotonous sheet of lymphoid cells with slightly contorted nuclei with a narrow rim of cytoplasm (figure and inset). Certainly, as a generalisation, for 90% of patients taking anticoagulants at least 90% of the time there is no major problem; when problems arise they are generally difficult whoever is involved in supervising anticoagulation, although it must be conceded the haematologist in this situation is usually in the best position to give clear advice as to practical short term management.
Despite good intentions most anticoagulant clinics end up as a thoroughly unsatisfactory professional experience. This is because they deliberately set out only to take responsibility for anticoagulation and not other clinical problems, such limited responsibility often confuses the patient and other groups of doctors. If haematologists should be the people running anticoagulation it would be better for them to have sufficient resources to have total specialist control of all such patients and firmly establish policies regarding duration of anticoagulation, indications, etc.
Surely it is time to take a step forward and either actively demythologise anticoagulant treatment and encourage general practitioners to take responsibility for anticoagulant control, with appropriate availability of support and help from consultant haematologists, or aim for haematology services to become fully equipped and resourced to offer a comprehensive anticoagulation service and assume a much greater degree of patient responsibility. 
